Proteomic signatures of COVID-19 Post-Vaccination/Post-Infection Syndrome (PV/PIS): insights into immune dysregulation and coagulopathy
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1753348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Maxine Waters und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa. Hauptthemen laut MEDLINE: COVID-19, Proteomics, COVID-19 Vaccines, Vaccination. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
During the global rollout of COVID-19 vaccines, a subset of individuals reported persistent symptoms following vaccination, with clinical presentations overlapping those of Long COVID and requiring individualised treatment strategies. Distinguishing between vaccine-related adverse events and post-infectious sequelae is challenging, particularly given the potential for unrecognised asymptomatic or mild SARS-CoV-2 infection before or after vaccination. To address this complexity, we defined our disease cohort as individuals experiencing persistent symptoms ( ≥ 12 weeks) following SARS-CoV-2 vaccination, without a confirmed history of prolonged symptoms after acute infection; for clarity, we refer to this group as presenting with Post-Vaccination/Post-Infection Syndrome (PV/PIS).
Methods
In this study, we conducted a plasma proteomic analysis of digested microclot deposits isolated from platelet-poor plasma samples of 14 individuals with PV/PIS compared to 16 healthy controls, using liquid-chromatography-mass spectrometry.
Results
We identified significant alterations in coagulation factors, acute phase proteins, and immune response modulators in the PV/PIS group compared to controls. Notably, elevated levels of serum amyloid A1 and A2, attractin, and coagulation factors X and XI were observed, alongside downregulation of immune-regulatory proteins. These findings suggest that PV/PIS is characterised by persistent immune dysregulation and coagulopathy.
Conclusions
This proteomic signature was found to only partially overlap with that previously reported in a proteomics analysis on Long COVID samples, collected prior to vaccination availability. Our results highlight the complex interplay between immune activation, endothelial dysfunction, and coagulation pathologies in PV/PIS, with distinct differences detected between these systems in Long COVID and PV/PIS, paving the way for more targeted protein research in these conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa.
- Trace Labs (PTY) LTD, Loevenstein, Cape Town, South Africa.
- South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
- Division of Chemical Pathology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Francie Van Zijl Drive, Tygerberg, Cape Town, South Africa.
- Division of Chemical Pathology, Department of Pathology, National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa.
- School for Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.
Zitieren
APA
Waters, M., Vlok, M., Kroon, E. E., Kotze, M. J., Moremi, K. E., Oladejo, S. O., Rajaratnam, K., Nunes, J. M., Venter, C., Scott, C. J., Kell, D. B., & Pretorius, E. (2026). Proteomic signatures of COVID-19 Post-Vaccination/Post-Infection Syndrome (PV/PIS): insights into immune dysregulation and coagulopathy. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1753348
Vancouver
Waters M, Vlok M, Kroon EE, Kotze MJ, Moremi KE, Oladejo SO, et al. Proteomic signatures of COVID-19 Post-Vaccination/Post-Infection Syndrome (PV/PIS): insights into immune dysregulation and coagulopathy. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1753348
BibTeX
@article{Waters2026,
author = {Waters, Maxine and Vlok, Mare and Kroon, Elouise E and Kotze, Maritha J and Moremi, Kelebogile E and Oladejo, Sunday O and Rajaratnam, Kanshukan and Nunes, Jean M and Venter, Chantelle and Scott, Chantelle J and Kell, Douglas B and Pretorius, Etheresia},
title = {Proteomic signatures of COVID-19 Post-Vaccination/Post-Infection Syndrome (PV/PIS): insights into immune dysregulation and coagulopathy},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1753348}
}
EUVIMED